Which statement about managing DIC is accurate?

Which statement about managing DIC is accurate?

• A. Heparin should be avoided in all cases
• B. Vitamin K is not prescribed for DIC
• C. Mefoxin is routinely used for DIC management
• D. Simvastatin is indicated for DIC management

Answer: (B)

Disseminated intravascular coagulation is driven by widespread clotting factor and platelet consumption, so treatment focuses on addressing the triggering cause and replacing what has been wasted rather than correcting a vitamin deficiency. Vitamin K helps with deficiencies or anticoagulant effects (like warfarin) but does not halt the ongoing consumption in DIC, so it is not prescribed as a routine therapy. The usual approach is to treat the underlying cause (for example, sepsis) and replace clotting components as needed with fresh frozen plasma and platelets; cryoprecipitate may be used if fibrinogen is low. In some cases, careful use of heparin can be considered to reduce ongoing thrombosis, but this depends on the bleeding risk and specific clinical scenario. Medications like Mefoxin or simvastatin aren’t direct treatments for DIC; the emphasis is on addressing the trigger and supporting coagulation through appropriate blood products.

Disseminated intravascular coagulation is driven by widespread clotting factor and platelet consumption, so treatment focuses on addressing the triggering cause and replacing what has been wasted rather than correcting a vitamin deficiency. Vitamin K helps with deficiencies or anticoagulant effects (like warfarin) but does not halt the ongoing consumption in DIC, so it is not prescribed as a routine therapy. The usual approach is to treat the underlying cause (for example, sepsis) and replace clotting components as needed with fresh frozen plasma and platelets; cryoprecipitate may be used if fibrinogen is low. In some cases, careful use of heparin can be considered to reduce ongoing thrombosis, but this depends on the bleeding risk and specific clinical scenario. Medications like Mefoxin or simvastatin aren’t direct treatments for DIC; the emphasis is on addressing the trigger and supporting coagulation through appropriate blood products.